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Abstract: Base excision repair (BER) may become less effective with ageing resulting in accumulation
of DNA lesions, genome instability and altered gene expression that contribute to age-related
degenerative diseases. The brain is particularly vulnerable to the accumulation of DNA lesions;
hence, proper functioning of DNA repair mechanisms is important for neuronal survival. Although
the mechanism of age-related decline in DNA repair capacity is unknown, growing evidence
suggests that epigenetic events (e.g., DNA methylation) contribute to the ageing process and
may be functionally important through the regulation of the expression of DNA repair genes.
We hypothesize that epigenetic mechanisms are involved in mediating the age-related decline in BER
in the brain. Brains from male mice were isolated at 3–32 months of age. Pyrosequencing analyses
revealed significantly increased Ogg1 methylation with ageing, which correlated inversely with
Ogg1 expression. The reduced Ogg1 expression correlated with enhanced expression of methyl-CpG
binding protein 2 and ten-eleven translocation enzyme 2. A significant inverse correlation between
Neil1 methylation at CpG-site2 and expression was also observed. BER activity was significantly
reduced and associated with increased 8-oxo-7,8-dihydro-2′-deoxyguanosine levels. These data
indicate that Ogg1 and Neil1 expression can be epigenetically regulated, which may mediate the
effects of ageing on DNA repair in the brain.
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1. Introduction
Ageing is associated with the accumulation of oxidative DNA damage resulting from increased
exposure to reactive oxygen species (ROS) from exogenous and endogenous sources [1]. DNA is
subject to constant attack by DNA-damaging agents, and the accumulation of unrepaired DNA
damage has profound effects on cell function. This may cause the characteristic features of ageing,
including changes in gene expression, genome instability, changes in cell replication, cell senescence
and cell death [2]. The DNA base guanine is particularly sensitive to oxidation by ROS to form
8-oxo-7,8-dihydro-2′-deoxyguanosine (8-oxodG) due to its low redox potential (reviewed by [3]).
The DNA glycosylase oxoguanosine 1 (OGG1) is the major base excision repair (BER) enzyme,
which recognizes and removes 8-oxodG from DNA. Other DNA glycosylases of interest are: (i) Nei
endonuclease VIII-like 1 (NEIL1), which recognizes and incises 8-oxodG lesions located near the
3′-end of single strand breaks, DNA bubble structures and single-stranded structures where OGG1
has limited activity [4]; and (ii) muty homolog (MUTYH), which has a specificity for adenine opposite
8-oxoguanine [5]. The DNA ligase and X-ray repair cross-complementing protein 1 (XRCC1) complex
complete the repair process by sealing the nick. Interestingly, OGG1 interacts with XRCC1, enhancing
its incision activity [6]. Whilst most oxidative damage is removed by BER and other DNA repair
mechanisms, it is thought that these mechanisms become less effective with ageing, resulting in the
accumulation of DNA lesions, loss of genome stability and altered gene expression that contribute
to age-related degenerative diseases. The role of DNA glycosylases dysfunction in ageing may be
important, as shown by age-related accumulation of oxidative damage in liver from Ogg1 KO mice [7].
Furthermore, the activity of human OGG1 declines with age in lymphocytes [8] and is lower in
Alzheimer’s disease brains [9,10]. Neil1 is highly expressed in the brain [11]. Binding between the DNA
damage sensor protein poly(ADP-ribose) polymerase 1 (PARP-1) and NEIL1 was diminished in older
mice compared with younger mice, supporting the idea of impaired DNA repair during aging [12].
The mechanisms responsible for age-related decline in DNA repair capacity are uncertain, but
growing evidence suggests that epigenetic events, including aberrant DNA methylation, contribute
to the ageing process and may be functionally important through dysregulation of gene expression
of, e.g., DNA repair genes [13–17]. Epigenetics defines processes and genomic markers, including
DNA methylation, covalent histone modifications and non-coding RNAs, that result in changes in
gene expression and phenotype without a corresponding alteration in DNA sequence, thus providing
a process for genome regulation. DNA methylation is the most widely-studied epigenetic mechanism
and is achieved by the addition of a methyl group to a cytosine (5mC) in CpG dinucleotides by DNA
methyltransferases [18]. CpGs are often densely packed in or close to promoter regions, forming
so-called “CpG islands”, which are normally unmethylated in expressed genes [19]. Whilst some
epigenetic markers are established during embryonic and foetal development and remain relatively
stable during adulthood, the methylation status of some genomic loci is labile and changes over time
and in response to environmental exposures [20,21]. Aberrant DNA methylation of CpG sites can
inhibit the opportunity for transcription factors (TF) to bind, which can lead to gene silencing [18].
In addition, ROS can cause oxidation of 5mC to 5-hydroxymethylcytosine (5hmC) [22], and although
the specific biological role of 5hmC is unclear, it may counteract transcriptional repression, making
5hmC important for gene regulation (reviewed by [23]). Alternatively, ten-eleven translocation (TET)
enzymes can convert 5mC to 5hmC and play a role in active DNA demethylation [22–24].
Evidence has been demonstrated for age-related changes in DNA methylation in studies of young
and older monozygotic twins [25]. Despite the identical genotypes, in older twins, there was greater
inter-twin variability in the epigenomes compared with younger twins, and this was accompanied
by greater inter-twin diversity in gene expression portraits. Interestingly, global DNA demethylation
has been accompanied by hypermethylation of specific gene promoters. Few studies have reported
investigations of promoter-specific methylation of genes involved in DNA repair [13–15,17,26–28];
these have been mainly in relation to cancer, and none have studied epigenetic regulation of BER-related
genes in the ageing brain.
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In the present study, the brain was selected as the target tissue since it is particularly vulnerable
to the deleterious effects of ROS due to its high oxygen utilization and relatively low antioxidants
levels [29,30]. DNA damage may be especially harmful in post-mitotic neuronal brain cells, which have
limited capacity to regenerate. Thus, oxidative DNA damage may play a key role in age-associated loss
of brain neurons; hence, cumulative unrepaired DNA damage may be responsible for the underlying
cellular dysfunction [31]. For these reasons, the proper functioning of DNA repair mechanisms is
important for neuronal survival.
We hypothesize that epigenetic mechanisms are involved in mediating the age-related decline in
DNA repair in the brain (Figure 1). Thus, through altered gene expression, changes in the methylation
status of promoters of genes encoding components of DNA repair systems may impact on neuronal
DNA repair. This may lead to the accumulation of oxidative DNA damage and mutations across
the whole genome, causing genome instability and increasing the risk of age-related degenerative
neurological diseases. To test this hypothesis, we studied: (i) the formation of oxidative DNA damage
and global DNA methylation levels; (ii) BER gene expression and the methylation status of CpGs
in TF binding sites that influence the transcription of BER genes; and (iii) correlations with the
resulting phenotypic BER-related incision activity in male mice across most of the adult lifespan
(3–32 months old).
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Figure 1. Schematic overview of the study hypothesis. Abbreviations used: 5mC, 5-methylcytosine;
5hmC, 5-hydroxymethycytosine; 8-oxodG, 8-oxo-7,8-dihydro-2′-deoxyguanosine; ROS: reactive oxygen
species; TET: ten-eleven translocation enzymes.
2. Materials and Methods
2.1. Animals and Design of the Study
Mice were obtained from a long-established colony of the C57/BL (ICRFa) strain, which had been
selected for use in studies of intrinsic ageing because it is free from specific age-associated pathologies
and, thus, provides a good general model of ageing [32]. Mice were housed in standard cages of
different sizes depending on housing density (between 1 and 6 mice per cage). Mice were housed
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at 20 ± 2 ◦C under a 12-h light/12-h dark photoperiod with lights on at 7 a.m. Mice were provided
with sawdust and paper bedding and had ad libitum access to water and food (CRM (P) Special Diet
Services; BP Nutrition Ltd., Essex, U.K.). All work complied with the U.K. Home Office Animals
(Scientific procedures) Act of 1986 (project licence PPL60/3864).
To study the effects of ageing, whole brains were collected from ad libitum fed male mice at ages
3, 6, 12, 24, 28, 31 and 32 months (n = 4 per age group, except 31 and 32 months, n = 3 per group),
immediately snap frozen in liquid nitrogen and stored at −80 ◦C. When required, frozen brain tissues
were ground and aliquoted and stored at −80 ◦C until further analysis.
2.2. Determination of 8-oxodG
Frozen ground brain tissues (~30–80 mg, n = 3–4 per group) were thawed, and genomic
DNA was isolated using standard phenol extraction [33]. The DNA extraction procedure was
optimized to minimize artificial induction of 8-oxodG, by using radical-free phenol, minimizing
exposure to oxygen and by the addition of 1 mM deferoxamine mesylate and 20 mM
TEMPO (2,2,6,6-tetramethylpiperidine-N-oxyl; Aldrich, Steinheim, Germany), according to the
recommendations made by the European Standards Committee on Oxidative DNA Damage
(ESCODD [34]). To detect the base oxidation product 8-oxodG, HPLC with electrochemical detection
(ECD) was performed as described earlier [35].
2.3. Assessment of Genomic 5mC and 5hmC
Nucleosides were derived from DNA samples (n = 3–4 per group) by digestion with DNA
Degradase Plus (Zymo Research, Cambridge Bioscience, Cambridge, U.K.) according to the
manufacturer’s instructions and were analysed by LC-MS/MS on an LTQ Orbitrap Velos mass
spectrometer (Thermo Scientific, Cramlington, UK) fitted with a nanoelectrospray ion-source
(Proxeon/Thermo Scientific; Amsterdam, The Netherlands). Mass spectral data for 5hmC, 5mC and C
were acquired in selected reaction monitoring (SRM) mode, monitoring the transitions 258→ 142.0611
(5hmC), 242→ 126.0662 (5mC) and 228→ 112.0505 (C). Parent ions were selected for SRM with a
4 mass unit isolation window and fragmented by Higher-energy Collisional Dissociation (HCD) with
a relative collision energy of 20%, with R > 14,000 for the fragment ions. Peak areas from extracted
ion chromatograms of the relevant fragment ions were quantified by external calibration relative to
authentic standards.
2.4. Gene-Specific Methylation Studies, Using Pyrosequencing of Bisulphite Converted DNA
Selection of transcription factor (TF) binding sites and Primer design: Genomatix’s
“Gene2Promoter” tool (Genomatix; Munich, Germany) was used to retrieve the target genes’ (i.e., Ogg1,
Neil1, Mutyh and Xrcc1) promoter sequence. Using the free, downloadable CpG Island Explorer
2.0 software ([36]; http://www.soft82.com/download/windows/cpg-island-explorer/), CpG-rich
regions were identified in the gene promoters. Next, the CpG-island was screened for TF binding
sites by means of the Genomatix “MatInspector” tool. The following selection criteria were applied:
core similarity >0.75 and matrix similarity >0.70 (with 1 being a perfect match), and optimized matrix
threshold >0.7 (to minimize the number of false positive matches). As advised by Genomatix, both (+)-
and (−)-strand matches have been considered equally, since most TF binding sites can occur in both
orientations in promoters or enhancers. Moreover, methylation patterns on the (+)- and (−)-strand
are believed to be identical since hemi-methylated DNA is restored to the fully-methylated state
during DNA replication [37]. All TF binding sites were subsequently filtered based on the association
of their TF family with specific tissues (based on MatInspector output); selecting those who are
ubiquitously expressed or specifically expressed in the brain/central nervous system/neurons. As a
second screening, only those TF that have at least one CpG di-nucleotide in their binding sequence
and preferably in their core sequence (i.e., the highest conserved, consecutive positions of the TF)
were selected. Based on these screening steps, CpG-sites located in TF binding sites with potential to
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influence promoter function were selected (Supplementary Materials Figures S1–S4). Using the PSQ
Software program (Qiagen, Manchester, U.K.), primers were designed for several amplicons to include
all selected CpG sites (Table 1 and Supplementary Materials Figures S1–S4).
Bisulphite conversion: DNA was extracted and purified (including RNase treatment) from ~20 mg
of ground tissue using standard chloroform:isoamyl alcohol extraction. Bisulphite conversion of DNA
was performed using the EZ DNA Methylation Gold™ kit (Zymo Research, Cambridge Bioscience,
Cambridge, U.K.) according to the manufacturer’s protocol.
Pyrosequencing: Bisulphite pyrosequencing was used to quantify methylation at individual
CpG sites within the specific TF binding sites. About 50 ng of bisulphite-treated DNA were added
as a template in PCR reaction containing 12.5 µL Hot Start Taq Master Mix (Qiagen, Manchester,
U.K.), 400 nM forward primer and 400 nM biotin-labelled reverse primer in a total volume of 25 µL.
The primer sequences and PCR conditions are summarized in Table 1. Amplification was carried out
in a Bio-Rad thermocycler (Bio-Rad, Hertfordshire, U.K.) using the following protocol; 95 ◦C 15 min,
then 50 cycles of 95 ◦C 15 s, annealing temperature for 30 s (Table 1), 72 ◦C for 30 s, followed by 72 ◦C
for 5 min. Next, the biotin-labelled PCR products were captured with Streptavidin Sepharose beads
(GE Healthcare, Amersham U.K.) and made single stranded using a Pyrosequencing Vacuum Prep Tool
(Qiagen). Sequencing primer (Table 1) was annealed to the single-stranded PCR product by heating
to 80 ◦C, followed by slow cooling. Pyrosequencing was then carried out on a Pyromark MD system
(Qiagen). Each sample was run in duplicate, and cytosine methylation was quantified by the Pyro Q
CpG 1.0.6 software (Qiagen, Manchester, U.K.). If poor quality data were obtained for both duplicates
or the assay failed (flagged in red by the software), that sample was omitted from further data analysis,
which was the case for 3 samples when running the Ogg1 pyrosequencing analyses and 4 samples in
the case of Neil1.
2.5. Gene Expression Analyses
Total RNA was extracted from brain samples (~20 mg) using TRIzol reagent (Ambion,
Life Technologies, Paisley, U.K.) according to the manufacturer’s protocol. Next, 500 ng of total
DNase-treated RNA were used for reverse transcription with the RevertAid™ H Minus First Strand
cDNA Synthesis Kit (Fermentas, Thermo Scientific, Cramlington, U.K.) at 45 ◦C for 1 h.
Real-time quantitative reverse transcription (RT)-PCR of cDNAs derived from specific transcripts
was performed in a Light Cycler 480 (Roche Diagnostics, Mannheim, Germany) using the respective
pairs of oligonucleotide primers (Table 2). cDNA (~25 ng) was mixed with 12.5 µL Maxima™ SYBR
Green qPCR Master Mix (Fermentas), 0.75 pmol of the forward and 0.75 pmol of the reverse primer
of our genes of interest, and RNase-free water was added to achieve an end volume of 25 µL.
Amplification was carried out using the following protocol; 95 ◦C for 10 min, then 45 cycles of 95 ◦C for
15 s and annealing temperature 60 ◦C for 1 min, with signal acquisition at extension steps. To confirm
amplification specificity, the PCR products from each primer pair were subjected to melt curve analysis
and agarose gel electrophoresis. Each sample was analysed in triplicate, and LightCycler 480 software
release 1.5.0 (Roche Diagnostics, Mannheim, Germany) was used for data analysis. Expression of Ogg1,
Neil1, Mutyh and Xrcc1 was normalized relative to that of control transcripts HPRT and β-microglobulin,
while the expression of Tet1–3 and Mecp2 was normalized to Atp5b and Gapdh. Levels of expressions,
also called Relative quantification (RQ) values, were obtained by the 2−∆∆Ct method. These RQ values
were subsequently log2 transformed to give the symmetric fold change.
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Table 1. Overview of primers and sequences to run pyrosequencing to study gene-specific methylation.
Gene Amplicon PCR Primers
Annealing
Temperature
(◦C)
Product
(bp) Sequencing Primers Sequence to Run on Pyrosequencer
Length
(bp)
Ogg1 1 Fw: 5′-GGTTTATTTTTTGAGATAGA-3′ 43 134 5′-TTTAGTTAAGTTTTAAA-3′ C/TGTGTTTTTC/TGTTTTTGTTTATC/TGAGTTTTGGGAC/TGATC/TGGTGTGTATTATTAC/TGTTTC/TG 60
Rev: 5′-BIO-ACTAAAACCACATCATTA-3′
2 Fw: 5′-GTAGGTTTTGAGATTGTAT-3′ 43 184 5′-GAAAGTTTTGAAATGGTAGA-3′ GTG/TGGGTTTTTGGTAGTTAATG/TGTTAAGTAGC/TGAGGTTAGTAGGTTAATC/TGTTTTTATTTTATAGGTTC/TGTTATTTC/TG 79
Rev: 5′-BIO-ATTTAACCCTAAAAATAAC-3′
Neil1 1 Fw: 5′-TGAGGTAGTAGTTAGTAAGG-3′ 52 220 5′-GTAGTTAGTAAGGGGTTAAT-3′ TTTAGTAGTTTGTC/TGAATTTTAGAGTAC/TGTTGGG 34
Rev: 5′-BIO-ACTCTACTCACAATTCTTT-3′ 5′-GAATGGAGTTTTTTATTTATGA-3′ GAATTTC/TGGGTGTTGGGTAACTTTTGGACTAGTC/TGC/TGTAATTC/TGGAGGTGAC/TGAA 55
2 Fw: 5′-AGAATTGTGAGTAGAGTTTTGT-3′ 52 186 5′-GTTTTAGTTATTTTAGATTATA-3′ C/TGTTAGTAGTC/TGGAAAC/TGGC/TGTTGTGTAGAGTTATAAGTAGTTGTATGC/TGAGG 53
Rev: 5′-BIO-ATCTTAAATCCCCAAAAATTA-3′
Mutyh 1 Fw: 5′-GGATGGTTATAGAAGTTTAAG-3′ 46.6 164 5′-GTTTTAGTTATTTTAGATTATA-3′ ATTTTTAGTGTGTAGC/TGC/TGTGTAATTGTAAAATTC/TG 36
Rev: 5′-BIO-TCACTACTCCACTCTACAA-3′
Xrcc1 1 Fw: 5′-AGGTTTTAGGAAATTTTTAGTT-3′ 50 228 5′-TTTAATGATTAGGGTAAA-3′ TTATAC/TGTAGGATTTAATTATTGAGGTC/TGTTTTTGTTGTTAGGTTTT AGGAGTC/TGAGTTTTTAG/TG 67
Rev: 5′-BIO-CCCTTAACAACAAACATTC-3′
2 Fw: 5′-TGTTTGTTGTTAAGGGAATT-3′ 50 328 5′-GGAGAGGTTTAATYGAGTAT-3′ GC/TGTAGTGTTGAC/TGTGTGC/TGTC/TGGC/TGC/TGTC/TGC/TGGTTTGAAAGGTTC/TGAGTTTTGC/TGC/TGTTTGC/TGT 65
Rev: 5′-BIO-CTCAAAAAACCCCTATCT-3′ 5′-GGGGTTTTTTYGGAGTTGTAA-3′ TTTTTTTTTTTTTATTTTTTTGGAC/TGGTC/TGGGC/TGTTTAC/TGGGC/TGTGGATATGTC/TGGAGATTAGTTTTC/TGTTAC/TGTC/TGT 76
BIO = indicates the biotin label on the reverse primers; Y = indicates the presence of an internal C/T wobble in the primer with a non-defined ratio.
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Table 2. Overview qPCR primers to study gene expression.
Primer set 1 Primer set 2
Gene q-PCR primers Gene q-PCR primers
Ogg1 Fw: 5′-TGGCTTCCCAAACCTCCAT-3′ Mecp2 Fw: 5′-GAGGAGGCGAGGAGGAGAGA-3′
Rev: 5′-GGCCCAACTTCCTCAGGTG-3′ Rev: 5′-AACTTCAGTGGCTTGTCTCTGAGG-3′
Neil1 Fw: 5′-GACCCTGAGCCAGAAGATCAG-3′ Tet1 Fw: 5′-CCATTCTCACAAGGACATTCACA-3′
Rev: 5′-AGCTGTGTCTCCTGTGACTT-3′ Rev: 5′-GCAGGACGTGGAGTTGTTCA-3′
Mutyh Fw: 5′-CTGTCTCCCCATATCATCTCTT-3′ Tet2 Fw: 5′-GCCATTCTCAGGAGTCACTGC-3′
Rev: 5′-TCACGCTTCTCTTGGTCATAC-3′ Rev: 5′-ACTTCTCGATTGTCTTCTCTATTGAGG-3′
Xrrc1 Fw: 5′-CTTCTCAAGGCGGACACTTA-3′ Tet3 Fw: 5′-GGTCACAGCCTGCATGGACT-3′
Rev: 5′-ATCTGCTCCTCCTTCTCCAA-3′ Rev: 5′-AGCGATTGTCTTCCTTGGTCAG-3′:
B2m Fw: 5′-ATGCTGAAGAACGGGAAAAAAA-3′ Atp5b Fw: 5′-GGCCAAGATGTCCTGCTGTT-3′
Rev: 5′-CAGTGTGAGCCAGGATATAGAA-3′ Rev: 5′-AACTTTGGCATTGTGGAAGG-3′
Hprt Fw: 5′-AGGAGAGAAAGATGTGATTGATATT-3′ Gapdh Fw: 5′-AACTTTGGCATTGTGGAAGG-3′
Rev: 5′-TCCACTGAGCAAAACCTCTT-3′ Rev: 5′-ATGCAGGGATGATGTTCTGG-3′
2.6. Measurement of BER-Related DNA Incision Activity
BER activity in brain tissues was assessed using a modified comet-based repair assay that was
recently optimized for the use of tissue extracts [38]. This assay measures the ability of BER-related
enzymes that are present in tissue extracts to recognize and incise substrate DNA containing 8-oxodG
lesions that were induced by the photosensitizer Ro 19-8022 plus light.
The protocol has been described in full detail before [38]. Briefly, to prepare tissue extracts, ~30-mg
aliquots of ground tissue were incubated with 75 µL Buffer A (45 mM HEPES, 0.4 M KCl, 1 mM EDTA,
0.1 mM dithiothreitol, 10% glycerol, adjusted to pH 7.8 (all purchased from Sigma, Dorset, U.K.)),
vortexed vigorously, snap frozen in liquid nitrogen and immediately defrosted. Next, 30 µL of 1%
Triton X-100 in Buffer A (Sigma, Dorset, U.K.) was added per 100-µL aliquot and incubated on ice for
10 min. After, centrifugation at 14,000× g for 5 min at 4 ◦C to remove cell debris, the supernatant was
collected, and protein concentrations were determined by the Bio-Rad DC Protein Assay Kit using
bovine serum albumin as a standard and controlling for the presence of Triton X-100. Final protein
extracts were diluted with 0.23% Triton X-100 in Buffer A to a concentration of 1 mg/mL before further
use in the repair incubation. Comets were visualized using an Olympus BX51 fluorescence microscope,
and 50 comets/slide selected at random were analysed using the Comet assay IV software program
(Perceptive Instruments, Haverhill, U.K.). %DNA in the tail (also known as tail intensity (TI)) was used
for further calculations. After subtracting background levels from all data, the final repair capacity
was calculated according to Langie et al. [38].
2.7. Statistical Analysis
Results are presented as the mean values ± standard error. Grubbs’ test, also called the ESD
method (extreme Studentized deviate), was used to determine significant outliers within the 8-oxodG
dataset; data from 5 samples were omitted. Differences in levels of genomic 5mC and 5hmC,
gene-specific DNA methylation, gene expression, BER-related incision activity and oxidative DNA
damage were analysed by ANOVA, using Dunnett’s t-test when comparing treatments. Relationships
between variables were assessed by regression analyses, conducting multiple linear stepwise regression
analysis when studying the effect of the various individual CpG-sites in TF binding sites on gene
expression. Statistical analysis was performed using SPSS v.19.0 (IBM), and p < 0.05 was considered
statistically significant.
3. Results
Our findings are structured according to the steps indicated in the schematic overview of our
study hypothesis (Figure 1).
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3.1. The Effect of Ageing on Genome Stability, DNA Damage and DNA Methylation
Ageing was associated with decreased global DNA methylation (5mC) (Figure 2A) and increased
5hmC (Figure 2B), though these trends were not statistically significant. However, there was a
significant effect of age on the 5hmC/5mC ratio (Figure 2C; PANOVA = 0.027), which increased
significantly in the older mice (R2 = 0.382, p = 0.008). In parallel, levels of 8-oxodG increased with age
(Figure 3A; R2 = 0.854, p = 0.025). Notably, higher 5hmC/5mC ratios were significantly associated with
higher levels of 8-oxodG (R2 = 0.785, p = 0.046).
Methylation of BER-related gene promotors tended to increase with age, especially in the oldest
mice (28 months) (Figure 3B). Methylation of the Ogg1 promotor (averaged across 27 CpG-sites;
Figure S1) increased significantly with age (PANOVA = 0.026; R2 = 0.416, p = 0.005), with the highest
effect observed in 28-month-old mice (p = 0.015 vs. three-month-old mice). The average methylation
level in the Xrcc1 promotor was also significantly affected by ageing (PANOVA = 0.023; R2 = 0.233,
p = 0.031): methylation levels in 28-month-old mice were increased compared with three-month-old
mice (PANOVA = 0.041). Methylation of four specific CpG-sites in the Xrcc1 promotor was affected
differentially by age (Figure S2). Averaged across 12 CpG-sites, Neil1 promotor methylation was not
significantly affected by age, but methylation of three individual CpG-sites was modulated during
ageing (Figure S3). Similarly, Mutyh average promotor methylation was not affected by age, but
methylation at CpG-site 3 was significantly decreased (Figure S4; PANOVA = 0.014). See Supplementary
Materials Figures S1–S4 for details of the individual CpG sites analysed and related TF binding sites
for these genes.
3.2. Effect of Ageing on Gene Expression in Mouse Brain
For the ease of comparison, gene expression was expressed as the fold change (calculated as log2 of
RQ values) compared with expression in three-month-old mice. In line with our hypothesis, there was
an overall decrease in BER-related gene expression with age (Figure 3C). This trend was not statistically
significant, except for Ogg1, where expression decreased significantly with age (PANOVA < 0.001;
P(24 vs. 3 months) < 0.001; P(28 vs. 3 months) < 0.001; and R2 = 0.692, p < 0.001). This expression change
correlated inversely with the average Ogg1 promoter methylation (Figure S5A; R2 = 0.320, p = 0.018).
Although Neil1 expression was not significantly affected by age (PANOVA = 0.080), there was a
significant inverse correlation between Neil1 expression and methylation levels at CpG-site 2
(Figure S5B; R2 = 0.545, p = 0.001). No correlations were observed between gene expression and
methylation for Xrcc1 and Mutyh.
3.3. Phenotypic Effects in the Ageing Brain
BER-related incision activity in the brain decreased significantly with age (Figure 3D;
PANOVA = 0.021). Although not statistically significant, a trend of lower BER activity with decreasing
levels of Ogg1 expression was observed (Figure S6A; R2 = 0.173, p = 0.068), which seemed to result in
higher levels of 8-oxodG lesions (Figure S6B; R2 = 0.149, p = 0.156). In addition, we observed weak
associations between these lower levels of BER-related incision activity and 5hmC levels (Figure S6C;
R2 = 0.229, p = 0.052), as well as 5hmC/5mC ratios (Figure S6D; R2 = 0.210, p = 0.064).
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Figure 2. Effect of ageing on genomic 5mC and 5hmC levels. Levels of: (A) genomic 5mC over total 
cytosine; (B) levels of 5hmC over total cytosine; and (C) ratio of 5hmC/mC (PANOVA = 0.027; R2 = 0.382, 
p = 0.008) in the brain of male mice. Percentages shown are calculated from the mean values (n = 4), 
and error bars represent standard errors of the mean (SEM). 
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p = 0.008) in the brain of ale ice. Percentages sho n are calculated from the mean values (n = 4),
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Figure 3. Effect of ageing on: (A) levels of 8-oxodG (R2 = 0.854, p = 0.025); (B) BER-related gene 
promotor methylation (Ogg1: PANOVA = 0.026, ** P(28 vs. 3 months) = 0.015; Xrcc1: PANOVA = 0.023,  
* P(28 vs. 3 months) = 0.041); (C) BER-related gene expression (Ogg1: PANOVA < 0.001, ** P(24 vs. 3 months) < 0.001, 
** P(28 vs. 3 months) < 0.001); and (D) BER-related incision activity (PANOVA = 0.021) in mouse brain. Data are 
presented as the mean values (n = 3–4), and bars indicate SEM. 
3.4. Involvement of Tet Enzymes and Methyl-CpG Binding Proteins 
To investigate the involvement of TET enzymes and methyl-CpG binding protein 2 (MECP2) in 
the effect of ageing on genomic DNA methylation, gene-specific methylation and gene expression, 
we measured the expression of Tet1–3 and Mecp2 genes (Figure 4). Tet2 (R2 = 0.332, p = 0.002), and 
Mecp2 (PANOVA = 0.003, P(28 vs. 3 months) = 0.050, P(31 vs. 3 months) = 0.039; R2 = 0.241, p = 0.011) expression 
increased significantly with age, while Tet1 (R2 = 0.154, p = 0.047) and Tet3 (PANOVA = 0.033; P(24 vs. 3 months) 
= 0.032, P(28 vs. 3 months) = 0.050, P(32 vs. 3 months) = 0.026; R2 = 0.228, p = 0.014) expression decreased with age.  
There was an inverse correlation between 5mC levels and Tet2 expression (Figure S7B; R2 = 0.327, 
PANOVA = 0.016) and lower levels of 5hmC with increasing Tet1 expression (Figure S7A; R2 = 0.444, 
PANOVA = 0.003). Increased levels of Ogg1 promotor methylation correlated significantly with 
increased Mecp2 expression (Figure S7C; R2 = 0.245, p = 0.043). Interestingly, Mecp2 expression also 
correlated inversely with Ogg1 expression (Figure S7D; R2 = 0.546, p < 0.001). 
Figure 3. Effect of ageing on: (A) levels of 8-oxodG (R2 = 0.854, p = 0.025); (B) BER-related gene
promotor methylation (Ogg1: PAN = 0.026, ** P(28 vs. 3 months) = 0.015; Xrcc1: PA = 0.023,
* P(28 s. 3 months) = 0.041); (C) BER-related gene expression (Ogg1: PANOVA < 0.001, ** P(24 vs. 3 months)
< 0.001, ** P(28 vs. 3 months) < 0.001); and (D) BER-related incision activity (PANOVA = 0.021) in mouse
brain. Data are presented as the mean values (n = 3–4), and bars indicate SEM.
3.4. I volve e t of et zy es a d ethyl- p inding Proteins
i esti ate t e i l e e t f e z es a et l- i i r tei 2 ( 2) i
t e effect f a ei e ic et lati , e e-s ecific et lati a e e ex ressi ,
e eas re t e expression of Tet1–3 and Mecp2 genes (Figure 4). Tet2 (R2 = 0.332, p = 0.002),
and Mecp2 (P NOVA = 0.003, P(28 v . 3 months) = 0.050, P(31 vs. 3 months) = 0.039; R2 = 0.241, p = 0.011)
expression increased significantly with age, while Tet1 (R2 = 0.154, p = 0.047) and Tet3 (PANOVA = 0.033;
P(24 vs. 3 months) = 0.032, P(28 vs. 3 months) = 0.05 , P(32 vs. 3 months) 0.026; R2 = 0.228, p = 0.014) expression
decreased with age.
There was an inverse correlation between 5mC levels and Tet2 expression (Figure S7B; 2 .327,
VA . 16) and lower levels of 5hmC with increasing Tet1 expression (Figure S7A; R2 = 0.444,
PANOVA = 0.003). Increased levels of Ogg1 promotor methylation correlated significantly with increased
Mecp2 expression (Figure S7C; R2 = 0.245, p = 0.043). Interestingly, Mecp2 expression also correlated
inversely with Ogg1 expression (Figure S7D; R2 = 0.546, p < 0.001).
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Figure 4. Expression of Tet1–3 and Mecp2 with ageing in mouse brain (* p = 0.050, ** p < 0.040,  
*** p = 0.026). Data are presented as the mean values (n = 3–4), and bars indicate standard errors of  
the mean. 
4. Discussion 
Several lines of evidence link ageing and genome maintenance pathways. Accelerated ageing is 
observed in mice defective in DNA repair pathways [39,40], and DNA repair deficiency in mature 
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certain forms of ataxia are caused by mutations in the BER-associated gene APTX, and mutations in 
NER-related genes (XPA-XPG) result in xeroderma pigmentosum, both syndromes that are 
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4–8-times higher than Tet3 expression levels (data not shown), which has been reported before in
adult cells [47]: Tet1 and Tet2 are believed to be important in maintaining pluripotency and adult
neurogenesis, while Tet3 is associated with cell differentiation and mainly involved in pre-natal
development [48,49]. In addition, TET3 was reported to mediate increased gene expression that was
associated with rapid behavioural adaptation, while TET1 was observed to alter 5hmC patterns during
adaptation to longer term stressful environmental exposures (reviewed by Madrid et al., 2016 [46]).
Furthermore, TET1, but not TET2 or TET3, may be involved in 5hmC production, which appears to be
essential for Purkinje cell viability and the prevention of ataxia-telangiectasia-like symptoms in mice
(reviewed by Madrid et al., 2016 [46]).
In the present study, lower 5mC levels were observed with increasing Tet2 expression, while
higher Tet1 expression seemed to correlate with lower levels of 5hmC. In general, TET enzymes are
the major enzymes catalysing conversion of 5mC to 5hmC, and thus, higher levels of 5hmC would be
expected to correlate with increased Tet1 expression, as was the case for Tet2. However, TET enzymes
also convert 5hmC to 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) [22,50,51], which could
explain the reduced levels of 5hmC observed in our study with increasing Tet1 expression. In our
current study, Tet1 expression decreased with ageing and can therefore not explain the accumulation
of 5hmC with ageing. However, Tet2 has recently been shown to catalyse the stepwise oxidation of
5mC oxidation and is able to generate 5fC and 5caC from a single encounter with 5mC [51]. However,
stalling at 5hmC was observed rather than progression to 5fC and 5caC. In addition, TET2 induction
in vitro resulted in increased levels of 5hmC [52]. Although TET2 has been studied most extensively in
various types of leukaemia [49], in the current study, Tet2 expression increased with ageing and was
inversely correlated with 5mC levels, which suggests that Tet2 might be responsible for the age-related
accumulation of 5hmC.
Alternatively, the conversion of 5hmC to cytosine may occur via deamination to
5-hydroxymethyluracil (5hmU), resulting in 5hmU-G mismatches that can be excised by BER DNA
glycosylases, such as thymine DNA glycosylase (TDG) and NEIL1 [49,53]. Although, Neil1 expression
decreased with age while 5hmC levels increased, we did not observe direct significant associations
between DNA glycosylases and 5hmC. In addition, the increased 5hmC levels and 5hmC/5mC ratios
with age were significantly associated with lower BER activity, which implies that the higher levels
of 5hmC in the ageing brain can be explained, at least partly, by the decreased BER-related incision
activity observed in the oldest mice. Recently, in TDG-/- cells, TET2-induced 5-hmC accumulation was
observed to result in GC > AT transitions [52], suggesting a mutagenic potential of 5-hmC metabolites
if not removed/repaired and which may increase the risk of developing neurological disorders.
4.2. Epigenetic Regulation of Ogg1 Plays a Role in Age-Related Decline in DNA Repair
Interestingly, age-related global DNA demethylation has been reported to occur concomitantly
with hypermethylation of specific CpG sites in the genome [44,54]. Of particular relevance for
the development of age-related disease, site-specific hypermethylation of promoter regions, and
transcriptional silencing, of tumour-suppressor genes can occur during aging [44]. Indeed, when using
pyrosequencing to quantify methylation at CpG sites in TF binding sites that can influence promoter
function, we observed significantly increased methylation of the BER-related Ogg1 gene promoter
with ageing. In addition, and possibly as a consequence, Ogg1 expression decreased significantly
in the oldest mice (Figure 3), and a significant inverse correlation between Ogg1 expression and
promotor methylation was observed (Figure S5). The lack of significant associations between increased
promotor methylation and reduced expression for the other BER-related genes could be explained by
the fact that bisulphite sequencing does not discriminate between 5mC and 5hmC (reviewed by [55]).
Thus, increased methylation levels might be explained by increased 5hmC levels, which may inhibit
the binding of methyl-CpG binding proteins and thereby counteract transcriptional repression of
5mC [23,47,56].
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Multiple linear regression analysis revealed an inverse correlation between Neil1 expression
and methylation levels of CpG-site 2 located in the binding sites of STAF (or zinc finger protein 143
(ZNF143)) and ZIC2 (Figure S2; CpG-site 2). Enhanced expression of ZNF143, a human homolog of
Xenopus transcriptional activator Staf, occurs in response to treatment with DNA-damaging agents [57]
and induces the expression of DNA repair genes, including the BER-related gene Fen-1. ZIC2 activates
the transcription of several genes and plays a crucial role in brain development [58].
Our observation of an inverse correlation between Mecp2 and Ogg1 expression is further evidence
for the epigenetic regulation of this gene (Figure S6). MeCP2 is a methyl-CpG binding protein that can
suppress transcription [59]. In the adult brain, MeCP2 binds to methylated DNA and plays a crucial
role in normal brain functioning.
In line with our hypothesis, the hypermethylation and decreased gene expression of BER-related
genes, especially Ogg1, with age was associated with reduced BER-related incision activity. We recently
confirmed this association in an independent ageing mice group, where we observed a 43% decrease
in Ogg1 expression and 20% decrease in BER activity in association with increased Ogg1 promotor
methylation in the brain [60]. Several studies have reported lower DNA repair activity in older
animals [11,61,62], although others have reported conflicting results [63–65]. The lack of direct
statistically-significant associations between the expression of the BER-related genes and BER-related
incision activity can be explained by the fact that studying gene expression does not necessarily
give any indication of enzyme activity. Nonetheless, the age-related decline in BER activity that we
observed was paralleled by a significant increase in 8-oxodG levels. This confirms earlier reports of
the accumulation of oxidative lesions with ageing [66], which may contribute to the development of a
senescent phenotype [67] and increase the risk of neurodegenerative diseases.
4.3. Concluding Remarks
We acknowledge the limitation of the size of this study, i.e., the relatively small numbers of
mice at each time point (3–4 mice), which, in some cases, may have led to high variability and
which may have reduced our ability to detect statistically-significant effects of ageing. Therefore,
we are cautious to extrapolate the weak associations observed between BER and 5hmC or 8-oxodG
levels. In particular, note that we analysed brain tissue from the oldest mice (31 and 32 months)
for Tet and Mecp2 expression only. Furthermore, the brain has a heterogenic mix of cell types with
different ratios of neurons to glia cells in the various brain regions. There is evidence that different
brain regions have distinct methylation profiles and may respond differently to ageing, which may
influence the development of neurodegenerative diseases. Recent studies have indicated a potential
role for 5hmC in various neurodegenerative diseases [46], so it will be important to investigate
age-related changes in DNA methylation patterns in the various brain regions. Indeed, in an earlier
study of brain from six-month-old mice, we reported region-specific patterns of 5mC and 5hmC
in the cortex and cerebellum [68]. In addition, we observed differential responses in 5mC and the
5hmC/5mC ratio in these two brain regions following dietary intervention [68]. Although overall
5hmC levels have been reported to increase with age in the brain, depletion of 5hmC was found in
the hippocampus, cerebellum and entorhinal cortex of patients suffering from Alzheimer’s disease
(AD) [46], while enrichment of 5hmC in the frontal and mid-temporal gyrus was positively correlated
with the hallmarks of AD. A recent investigation of the genome-wide distribution of 5hmC in a
mouse model of Huntington’s disease (HD) found reduced levels of 5hmC in the mouse striatum and
cortex tissues.
In terms of gene-specific methylation profiles, age-related DNA methylation changes are most
often observed in CpG islands (as studied in the gene promotors of BER-related genes in the
current study), while tissue-specific differences are observed more frequently outside those sites [54].
Future studies of the mechanisms underlying these marked effects of ageing on brain function
could also include other genomic domains, e.g., CpG island shores, which are susceptible to altered
methylation in response to environmental exposures and which may be important in regulating
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expression of the corresponding genes. A number of reports show that DNA methylation at intragenic
regions (reviewed in Kulis et al., 2013 [69]), CpG island shores [70], partially-methylated domains [71]
or long hypomethylated domains [72,73] can influence gene expression. In addition, it may be
informative to investigate gene-specific 5hmC and 5mC levels, since Tet1-assisted bisulphite sequencing
has become an established method for 5hmC detection [46]. Moreover, it will be important to broaden
the enquiry to include other epigenetic marks and post-translational modifications, since these work
together in a coordinated manner to regulate gene expression.
In addition to the investigation of different brain regions, it would be interesting to investigate the
effects of ageing on specific sub-cellular fractions. Increased levels of 8-oxodG lesions during ageing
have been reported for nuclear DNA (nDNA) and to a higher extent for mitochondrial DNA (mtDNA).
Indeed, the degree of mtDNA oxidative damage in neuronal tissue appears to be inversely related
to the maximum life span potential in mammals (reviewed by Gredilla et al., 2010 [74]). Since Ogg1
is one of the most extensively-investigated mitochondrial DNA glycosylases and recent reports also
show the presence of Neil1 in brain mitochondria (reviewed by Gredilla et al., 2010 [74]), changes in
BER-related gene methylation and expression may have a bigger impact on mitochondrial than on
nuclear DNA damage and function and, subsequently, on brain ageing. Interestingly, altered mtDNA
methylation profiles in human brain have recently been linked to AD and Parkinson’s disease [75].
Although, quantification of mtDNA methylation is still challenging [76], immunoprecipitation methods
(e.g., methylated DNA immunoprecipitation (MeDIP)) in combination with microarray hybridization,
as well as mass spectrometry-based analysis have been proven very useful in the detection of mtDNA
methylation (reviewed by Castegna et al., 2015 [77]).
Although, an increasing number of studies focus on elucidating the molecular events that lead
from accumulation of DNA damage, to loss of cellular function and, ultimately, neurodegeneration,
further studies are needed to understand the molecular mechanisms underlying age-related changes
in DNA repair capacity. The current study helps to solve part of the puzzle and provides evidence
that epigenetic mechanisms, i.e., increased Ogg1 promoter methylation and the involvement of Tet
enzymes and Mecp2, may affect gene expression in the ageing mammalian brain, which could impact
the capacity for neuronal DNA repair. Overall, our data suggest that the accelerated accumulation of
oxidative DNA damage may be mediated by epigenetic dysregulation of BER activity, causing genome
instability and increasing the risk of age-related degenerative neurological diseases.
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Abbreviations
The following abbreviations are used in this manuscript:
5caC 5-carboxylcytosine
5fC 5-formylcytosine
5hmC 5-hydroxymethycytosine
5mC 5-methylcytosine
8-oxodG 8-oxo-7,8-dihydro-2′-deoxyguanosine
BER base excision repair
Mecp2 methyl-CpG binding protein 2
Mutyh mutY DNA glycosylase
nDNA nuclear DNA
NER nucleotide excision repair
Neil1 Nei-like DNA glycosylase 1
mtDNA mitochondrial DNA
Ogg1 DNA glycosylase oxoguanosine 1
ROS reactive oxygen species;
TDG thymine DNA glycosylase
TEMPO 2,2,6,6-tetramethylpiperidine-N-oxyl
TET ten-eleven translocation enzymes
TF transcription factors
Xrcc1 X-ray repair cross-complementing protein 1
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